“Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer”. Journal of Analytical Oncology, vol. 4, no. 1, Jan. 2015, pp.  44-51, https://doi.org/10.6000/1927-7229.2015.04.01.8.